Insulet Corporation (PODD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Insulet Corporation (PODD) is down 51.1% since the beginning of the year. At $139 per share, PODD is trading 60.8% below its 52-week high of $355. Investors who bought $1,000 worth of PODD shares 5 years ago would now be looking at an investment worth $495.

Insulet Corporation (PODD) has returned -51.11% so far this year and -54.16% over the past 12 months. Looking at the last ten years, PODD has achieved an annualized return of 17.15%, outperforming the S&P 500 Index benchmark, which averaged 13.88% per year.

Based on dividend-adjusted daily data since May 15, 2007, PODD's average daily return is +0.09%, while the average monthly return is +1.84%. At this rate, an investment would double in approximately 3.2 years.

Historically, 54% of months were positive and 46% were negative. The best month was Dec 2008 with a return of +57.9%, while the worst month was Oct 2008 at -59.8%. The longest winning streak lasted 6 consecutive months, and the longest losing streak was 7 months.

On a daily basis, PODD closed higher 52% of trading days. The best single day was Mar 12, 2009 with a return of +32.6%, while the worst single day was Mar 6, 2009 at -34.3%.

Insulet Corporation has an annualized alpha of 12.85%, beta of 1.12, and R2 of 0.19 versus S&P 500 Index. Calculated based on daily prices since May 15, 2007.

• This stock captured 137.75% of S&P 500 Index gains and 120.85% of its losses - amplifying both gains and losses, but participating more in upside than downside.
• R2 of 0.19 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

PODD ranks 3 for risk / return — in the bottom 3% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Insulet Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Insulet Corporation was 90.28%, occurring on Mar 11, 2009. Recovery took 1046 trading sessions.

The current Insulet Corporation drawdown is 60.61%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Insulet Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Insulet Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.